Gastric Space Occupying Devices Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview

The Gastric Space Occupying Devices Market is projected to grow from USD 219.2 million in 2024 to approximately USD 299.99 million by 2032, reflecting a compound annual growth rate (CAGR) of 4% during the forecast period.

The market's growth is largely driven by the rising global prevalence of obesity and related comorbidities such as type 2 diabetes, cardiovascular diseases, and joint disorders. As awareness increases regarding the health risks associated with obesity, more patients are turning to minimally invasive weight loss interventions. Gastric space-occupying devices—including intragastric balloons and oral palatal inserts—provide non-surgical, temporary, and reversible solutions for patients who may not be eligible for or are unwilling to undergo bariatric surgery.

Additionally, rising disposable incomes in emerging markets and growing awareness of the health benefits of weight loss are contributing to increased demand. Technological innovations, particularly in device design, materials, and delivery systems, are also enhancing treatment outcomes and safety, further encouraging adoption among both healthcare professionals and patients.
Market Drivers
1. Technological Advancements in Device Design and Materials

Innovation in the field of biocompatible materials and ergonomic device design has significantly improved the safety and efficacy of gastric space-occupying devices. Modern systems are more comfortable, customizable, and easier to deploy.

For example, the Orbera® Intragastric Balloon System from Apollo Endosurgery features adjustable volume and biocompatible materials, allowing for personalized patient treatment plans. Enhanced delivery mechanisms have also reduced the invasiveness of procedures, making them more acceptable to patients and facilitating broader adoption by healthcare providers. These improvements have instilled greater confidence in the technology and are accelerating its global expansion.
Market Challenges
1. High Treatment Costs and Limited Insurance Coverage

A major barrier to the widespread adoption of gastric space-occupying devices is the high cost of treatment. These expenses typically include not only the device itself but also procedural fees, clinical monitoring, and post-treatment care. In many regions, especially in developing countries, this cost burden is compounded by the lack of insurance reimbursement for non-surgical weight loss therapies.

Without sufficient healthcare coverage, patients are often required to pay out of pocket, significantly limiting access to treatment—particularly in cost-sensitive or resource-constrained environments.
Market Segmentation
By Product Type

Gastric Balloons

Oral Palatal Space Occupying Devices

By End User

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Region

North America: U.S., Canada, Mexico

Europe: Germany, France, U.K., Italy, Spain, Rest of Europe

Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific

Latin America: Brazil, Argentina, Rest of Latin America

Middle East & Africa: GCC Countries, South Africa, Rest of MEA

Key Market Players

Allurion Technologies, Inc.

Apollo Endosurgery, Inc.

Endalis

Helioscopie

Lexel Medical

MEDSIL

Obalon Therapeutics, Inc.

ReShape Medical, Inc.

Scientific Intake


1. Executive Summary
1.1 Market Overview
1.2 Key Findings
1.3 Market Opportunities and Trends
1.4 Strategic Recommendations
2. Introduction
2.1 Report Scope and Definition
2.2 Research Methodology
2.3 Assumptions and Limitations
3. Market Overview and Dynamics
3.1 Overview of Gastric Space Occupying Devices
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Regulatory and Reimbursement Landscape
3.6 Impact of Obesity and Bariatric Trends
4. Market Segmentation Analysis
4.1 By Product:
Intragastric Balloons
Endoscopic Suturing Devices
Gastric Bands
Others
4.2 By End-User:
Hospitals
Ambulatory Surgical Centers
Specialized Weight Loss Clinics
Others
4.3 By Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
5. Technology and Innovation Landscape
5.1 Advancements in Minimally Invasive Procedures
5.2 Biocompatible Materials in Device Design
5.3 Integration with Digital Weight Loss Management Tools
6. Competitive Landscape
6.1 Market Share Analysis
6.2 Competitive Benchmarking
6.3 Recent Developments (M&A, Partnerships, Product Launches)
7. Key Player Analysis
In-depth profiles covering financials, product portfolios, clinical developments, and strategic initiatives:
Allurion Technologies, Inc.
Apollo Endosurgery, Inc.
Endalis
Helioscopie
Lexel Medical
MEDSIL
Obalon Therapeutics, Inc.
ReShape Medical, Inc.
Scientific Intake
8. Market Forecast and Opportunity Analysis
8.1 Market Size Estimations (2024–2030)
8.2 Forecast by Product, End-User, and Region
8.3 Emerging Markets and Investment Opportunities
9. Conclusion and Strategic Outlook
9.1 Summary of Key Insights
9.2 Future Outlook
9.3 Recommendations for Stakeholders
10. Appendices
10.1 Glossary
10.2 List of Abbreviations
10.3 Research Methodology Details
10.4 References

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings